Elevation Wealth Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8K Buy
192
+36
+23% +$3.39K ﹤0.01% 706
2026
Q1
$18.4K Buy
156
+30
+24% +$3.71K 0.01% 397
2025
Q4
$15.9K Sell
126
-1,010
-89% -$132K 0.01% 415
2025
Q3
$166K Buy
1,136
+34
+3% +$5.14K 0.06% 129
2025
Q2
$172K Buy
1,102
+1
+0.1% +$159 0.07% 122
2025
Q1
$181K Hold
1,101
0.08% 117
2024
Q4
$179K Hold
1,101
0.08% 122
2024
Q3
$215K Buy
1,101
+1
+0.1% +$184 0.09% 109
2024
Q2
$191K Hold
1,100
0.09% 112
2024
Q1
$186K Hold
1,100
0.09% 112
2023
Q4
$191K Hold
1,100
0.11% 106
2023
Q3
$191K Hold
1,100
0.17% 63
2023
Q2
$189K Sell
1,100
-238
-18% -$41.1K 0.16% 63
2023
Q1
$223K Buy
+1,338
New +$219K 0.2% 58

Other funds holding ZTS

Elevation Wealth Partners's ZTS Position: Q2 2026 in Review

Elevation Wealth Partners increased its Zoetis (ZTS) stake by 23% in Q2 2026, buying an estimated $3.39K and bringing the position to 192 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #706.

Elevation Wealth Partners first reported a position in ZTS in Q1 2023 and has held it in 14 quarters since. The position peaked at $223K in Q1 2023. 274 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Elevation Wealth Partners held 192 shares of Zoetis worth $13.8K as of Q2 2026.
  • Elevation Wealth Partners bought 36 Zoetis shares in Q2 2026, an estimated $3.39K.
  • Zoetis made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #706 holding.
  • Elevation Wealth Partners first reported a position in Zoetis in Q1 2023 and has held it in 14 quarters since.
  • Elevation Wealth Partners's Zoetis position peaked at $223K in Q1 2023.
  • 274 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.